Discontinuation report DEMEROL
Report ID | 98380 |
Drug Identification Number | 02138018 |
Brand name | DEMEROL |
Common or Proper name | Demerol |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | MEPERIDINE HYDROCHLORIDE |
Strength(s) | 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N02AB |
ATC description | OPIOIDS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2020-05-31 |
Actual discontinuation date | 2020-07-02 |
Remaining supply date | 2020-06-15 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Last lot number Distributed 8119897 with expiry date 2023-04-18 |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2020-07-29 | French | Compare |
v9 | 2020-07-29 | English | Compare |
v8 | 2020-03-24 | French | Compare |
v7 | 2020-03-24 | English | Compare |
v6 | 2020-01-24 | French | Compare |
v5 | 2020-01-24 | English | Compare |
v4 | 2019-12-11 | French | Compare |
v3 | 2019-12-11 | English | Compare |
v2 | 2019-11-11 | French | Compare |
v1 | 2019-11-11 | English | Compare |
Showing 1 to 10 of 10